NCT Number: NCT06344832
SSTR PET/CT for Preoperative N Stage Evaluation in GEP-NETs
The research aims to prospectively include patients with GEP-NENs, undergo preoperative imaging assessment (including PET/CT and contrast-enhanced CT), and accurately delineate lymph node regions. Through postoperative pathological reports, the diagnostic performance of lymph node metastasis (LNM) in GEP-NENs is evaluated. Factors influencing the diagnostic accuracy of SSTR-PET/CT and contrast-enhanced CT are also investigated.
Trial opening soon.
Get NotifiedKey information
Age range
18 year and older
Sex eligibility
All sexes
Study type
Observational
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Age > 18 years old;
- Patients diagnosed with GEP-NEN by surgical pathology;
- Complete medical records including basic information and treatment process;
- Patients who have undergone preoperative contrast-enhanced CT and 68Ga-SSTR-PET/CT, and have consented to the 68Ga-SSTR-PET/CT project in the Nuclear Medicine Department.
Exclusion criteria
- Presence of concomitant malignancies;
- Cases diagnosed pathologically as non-GEP-NEN.
Treatment and study plan
Primary outcomes
-
lymph node metastasis status
Time frame: 2024.04.01~2030.03.01
lymph node metastasis status confirmed by histopathology
Sponsors and collaborators
Lead sponsor
Peking Union Medical College Hospital
Other
Registry information
Official study title
Somatostatin Receptor Antagonist PET/CT for Pre-operative N Stage Evaluation in Patients With Gastro-entero-pancreatic Neuroendocrine Tumors
Important dates
- Study start
- 2024
- Primary completion
- 2028
- Study completion
- 2030
- First posted
- Apr 3, 2024
- Registry last updated
- Apr 3, 2024
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.